ÂÜÀòÂÒÂ×

Mr. Blickenstaff is the Executive Chairman and Director of Tandem Diabetes Care, Inc., and previously served as the company’s President and Chief Executive Officer. Prior to that, he served as Chairman and Chief Executive Officer of Biosite Incorporated, a provider of medical diagnostic products, from 1988 until its acquisition by Inverness Medical Innovations, Inc. in 2007. Mr. Blickenstaff previously served as a Director of Medivation, Inc., until its acquisition by Pfizer in 2016, and a Director of DexCom, Inc., a provider of continuous glucose monitoring systems. Mr. Blickenstaff was formerly a certified public accountant and has more than 20 years of experience overseeing the preparation of financial statements. He held various positions in finance, operations, research management, sales management, strategic planning and marketing with Baxter Travenol, National Health Laboratories and Hybritech Incorporated. He received a B.A. in political science from Loyola University Chicago and an M.B.A. from the Graduate School of Business, Loyola University Chicago.